IL22RA1 and Hyperglycemia: The targeted deletion of IL-22ra1 in pancreatic beta-cells also precipitates age-dependent hyperglycemia, alongside heightened cellular stress and inflammation, without inducing insulin resistance at 20 weeks of age.